Indication
1. New marker for pediatric Sepsis evaluation
Efficacy (Small trial: N=177 with 18 septic infants)
1. Test Sensitivity: 100%
2. Test Specificity: 100%
  1. Only septic children had significant proCT increase
  2. Other children had no increase or a mild increase
Advantages
1. Requires only 20 ul plasma
2. Lab runs in only 2 hours
Reference
1. Gendrel (1996) J Pediatr 128:570

procalcitonin (C0072027)
Concepts	Amino Acid, Peptide, or Protein (T116) , Biologically Active Substance (T123)
English	Calcitonin precursor polyprotein, procalcitonin
Spanish	procalcitonina
Credits	Derived from the NIH UMLS (Unified Medical Language System)

Navigation Tree

Please see the Terms and Conditions. Please also see the privacy statement regarding advertising on this page. Although access to this page is not restricted, the information found here is intended for use by medical providers. Patients should address specific medical concerns with their physicians.

This page was written by Scott Moses, MD. This page was last revised before 5/10/08, prior to consistent tracking of revision date. This page was last published on 5/10/2008. Please send comments and questions to the editor. Contact information may be found on the page About the Family Practice Notebook. These pages are best viewed with Microsoft Internet Explorer 6.0.

Hematology and Oncology Book

Acute Phase Reactant

Anemia

Bone Marrow Disorders

Cancer

Coagulopathy

Complete Blood Count

Hemolytic Disorders

Miscellaneous

Platelet Disorders

Infectious Disease Chapter related topics

Pharmacology Chapter related topics

http://www.fpnotebook.com/

ProcalcitoninAka: proCT

procalcitonin (C0072027)

Navigation Tree